Literature DB >> 2719077

Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis.

T A Drake1, J H Morrissey, T S Edgington.   

Abstract

Tissue factor (TF), the primary cellular initiator of the coagulation protease cascade, is implicated in having important roles in hemostasis, thrombogenesis, inflammation, and the cellular immune response, although the cytologic distribution of TF in tissues has yet to be described. This study used epitope-defined monoclonal antibodies to human tissue factor for immunohistochemical localization of TF in normal human tissues. TF was selectively expressed in tissues and was associated with cells rather than extracellular matrix. It was anatomically sequestered from blood, being undetectable in endothelium and peripheral blood cells. TF was present in vascular adventitia, organ capsules, epidermis, and mucosal epithelium. Most dermal and submucosal fibroblasts were negative. Except for alveolar macrophages and possibly dendritic cells of some lymphoid follicles, tissue macrophages did not express TF; (expression was demonstrable in LPS stimulated monocytes). Cerebral cortex, renal glomeruli, and cardiac myocytes were additional sites of prominent TF expression. Based on the cellular distribution of TF, it is hypothesized that intravascular initiation of coagulation requires induced expression by intravascular cells, and that the normal distribution of TF represents a hemostatic "envelope" ready to activate coagulation when vascular integrity is disrupted.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2719077      PMCID: PMC1879887     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  40 in total

1.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

2.  A mechanism of migration inhibition in delayed-type hypersensitivity reactions. I. Fibrin deposition on the surface of elicited peritoneal macrophages on vivo.

Authors:  K E Hopper; C L Geczy; W A Davies
Journal:  J Immunol       Date:  1981-03       Impact factor: 5.422

3.  Suppression of endogenous avidin-binding activity in tissues and its relevance to biotin-avidin detection systems.

Authors:  G S Wood; R Warnke
Journal:  J Histochem Cytochem       Date:  1981-10       Impact factor: 2.479

4.  The use of avidin-biotin interaction in immunoenzymatic techniques.

Authors:  J L Guesdon; T Ternynck; S Avrameas
Journal:  J Histochem Cytochem       Date:  1979-08       Impact factor: 2.479

5.  Mononuclear cell tissue factor: cell of origin and requirements for activation.

Authors:  R L Edwards; F R Rickles; A M Bobrove
Journal:  Blood       Date:  1979-08       Impact factor: 22.113

6.  An alternative extrinsic pathway of human blood coagulation.

Authors:  R A Marlar; A J Kleiss; J H Griffin
Journal:  Blood       Date:  1982-12       Impact factor: 22.113

7.  Leukocyte procoagulant activity in man: an in vitro correlate of delayed-type hypersensitivity.

Authors:  C L Geczy; P A Meyer
Journal:  J Immunol       Date:  1982-01       Impact factor: 5.422

8.  Monoclonal antibodies against simian virus 40 T antigens: evidence for distinct sublcasses of large T antigen and for similarities among nonviral T antigens.

Authors:  E G Gurney; R O Harrison; J Fenno
Journal:  J Virol       Date:  1980-06       Impact factor: 5.103

9.  Efficacy of prothrombin-complex concentrates in hemophiliacs with antibodies to factor VIII: a multicenter therapeutic trial.

Authors:  J M Lusher; S S Shapiro; J E Palascak; A V Rao; P H Levine; P M Blatt
Journal:  N Engl J Med       Date:  1980-08-21       Impact factor: 91.245

10.  Induction of monocyte procoagulant activity by murine hepatitis virus type 3 parallels disease susceptibility in mice.

Authors:  G A Levy; J L Leibowitz; T S Edgington
Journal:  J Exp Med       Date:  1981-10-01       Impact factor: 14.307

View more
  315 in total

Review 1.  New thrombolytics, anticoagulants, and platelet antagonists: the future of clinical practice.

Authors:  R C Becker
Journal:  J Thromb Thrombolysis       Date:  1999-04       Impact factor: 2.300

2.  Coagulation protein function VII: diametric effects of acetaldehyde on factor VII and factor IX function.

Authors:  D A Sabol; M H Basista; A S Brecher; K Haider; J Kleshinski
Journal:  Dig Dis Sci       Date:  1999-12       Impact factor: 3.199

3.  Adjunctive Pharmacologic Treatment: Focus on the Development of Low Molecular Weight Heparins.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1997       Impact factor: 2.300

Review 4.  Report of the NASPE/NHLBI Round Table on Future Research Directions in Atrial Fibrillation. North American Society of Pacing and Electrophysiology.

Authors:  S Saskena; M J Domanski; E J Benjamin; A J Camm; M D Ezekowitz; B J Gersh; J Jalife; G V Naccarelli; R E Vlietstra; D G Wyse
Journal:  J Interv Card Electrophysiol       Date:  2001-09       Impact factor: 1.900

5.  Lipopolysaccharide induction of tissue factor expression in rabbits.

Authors:  J Erlich; C Fearns; J Mathison; R J Ulevitch; N Mackman
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

Review 6.  Tissue factor and thrombosis: The clot starts here.

Authors:  A Phillip Owens; Nigel Mackman
Journal:  Thromb Haemost       Date:  2010-06-10       Impact factor: 5.249

7.  Severe traumatic brain injury is associated with a unique coagulopathy phenotype.

Authors:  Jason M Samuels; Ernest E Moore; Christopher C Silliman; Anirban Banerjee; Mitchell J Cohen; Arsen Ghasabyan; James Chandler; Julia R Coleman; Angela Sauaia
Journal:  J Trauma Acute Care Surg       Date:  2019-04       Impact factor: 3.313

8.  p21-activated kinase-1 signaling regulates transcription of tissue factor and tissue factor pathway inhibitor.

Authors:  Beatriz Sánchez-Solana; Mona Motwani; Da-Qiang Li; Jeyanthy Eswaran; Rakesh Kumar
Journal:  J Biol Chem       Date:  2012-10-04       Impact factor: 5.157

9.  Tissue factor-dependent coagulation contributes to alpha-naphthylisothiocyanate-induced cholestatic liver injury in mice.

Authors:  James P Luyendyk; Glenn H Cantor; Daniel Kirchhofer; Nigel Mackman; Bryan L Copple; Ruipeng Wang
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-01-29       Impact factor: 4.052

Review 10.  Spatiotemporal regulation of coagulation and platelet activation during the hemostatic response in vivo.

Authors:  L Ivanciu; T J Stalker
Journal:  J Thromb Haemost       Date:  2015-10-23       Impact factor: 5.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.